ViralClear opened enrollment with first patient dosing in phase II human trial of anti-viral MMPD oral solution for treatment of COVID-19
| | | |

ViralClear opened enrollment with first patient dosing in phase II human trial of anti-viral MMPD oral solution for treatment of COVID-19

On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…

Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank
| | | | | | |

Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank

On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…

UNMC awarded $12 million grant by the Dept of HHS to establish and co-lead the nation’s National Ebola Training and Education Center
| | | | | |

UNMC awarded $12 million grant by the Dept of HHS to establish and co-lead the nation’s National Ebola Training and Education Center

On Jul. 1, 2015, the UNMC/Nebraska Medicine, in collaboration with Emory University in Atlanta and Bellevue Hospital Center…